AMA Submission to Health Technology Assessment Policy and Methods Review – Consultation 1
The AMA supports the aims and the purpose of the Health Technology Assessment Policy and Methods Review.
![](/sites/default/files/styles/limit_height/public/2023-06/istockphoto-1191534412-612x612.jpg?itok=ClH6Z3hG)
The AMA expects that the HTA review will ensure Australians have timely and affordable access to essential therapeutics. The submission outlines that the review process must:
- Allow medical practitioners to feel confident in the safety, efficacy and accessibility when prescribing of medicines and therapeutic treatments for any patient
- Provide, within reason, for industry to support Australian specialists in their use of specific therapeutics
- Ensure that patients do not face excessive out of pocket costs for essential and lifesaving therapeutics.